Compositions comprising alkyldimonium hydroxypropyl alkylglucosides
OwnerErning Xia, Kimberly Millardinventors
Life of this patent
Estimating the term…
Abstract
A pharmaceutical formulation for topical, ophthalmic or nasal administration comprising one or more alkyldimonium hydroxypropyl alkylglucosides of general formula I or general formula II and a pharmaceutical active, wherein R is a straight or branched C8-C24alkyl; A is —CH2CH(OH)CH2N+(CH3)2R1X−, wherein R1 is a C8-C24alkyl and X− is a common counteranion, n is an average value from 1 to 6 and m is an average value from 1 to 2
Claims16
A formulation comprising one or more alkyldimonium hydroxypropyl alkylglucosides of general formula I or general formula II and a pharmaceutical active,
- wherein R is a straight or branched C8-C24alkyl;
- A is —CH2CH(OH)CH2N+(CH3)2R1X−, wherein R1 is a C8-C24alkyl and X− is a common counteranion, and a n is an average value from 1 to 6 and m is an average value from 1 to 2, wherein the formulation is a pharmaceutical formulation for topical, ophthalmic or nasal administration.
A formulation comprising one or more alkyldimonium hydroxypropyl alkylglucosides selected from the group consisting of stearyldimonium hydropropyl laurylglucoside, stearyldimonium hydropropyl decylglucoside and poly(lauryldimonium hydroxypropyl laurylglucosides chloride, wherein the formulation is a pharmaceutical formulation for ophthalmic or nasal administration.
Dependencies are inferred from the claim text.